Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2019/86 | Other Identifier | Clinical Research Ethics Committee |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This prospective pilot study aims to evaluate the efficacy of a structured 8-week multimodal pulmonary rehabilitation (PR) program specifically designed for patients with radiographic axial spondyloarthritis (r-axSpA). The study assesses the impact of a composite intervention incorporating aerobic conditioning, resistance training, flexibility protocols, and targeted diaphragmatic breathing on functional exercise capacity, dyspnea severity, and pulmonary function.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Multimodal Pulmonary Rehabilitation | Experimental | Patients with radiographic axial spondyloarthritis (r-axSpA) receiving an 8-week structured multimodal pulmonary rehabilitation program. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Multimodal Pulmonary Rehabilitation | Behavioral | An 8-week structured exercise program consisting of three sessions per week (two supervised hospital-based sessions and one structured home-based session). The intervention integrates aerobic conditioning using a treadmill and arm ergometer, resistance and mobility training targeting spinal extension, and specific respiratory muscle training including diaphragmatic and pursed-lip breathing maneuvers. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in 6-Minute Walk Distance (6MWD) | Functional exercise capacity is measured by the total distance walked in 6 minutes, recorded in meters. Higher values indicate better functional exercise capacity (better outcome). | Baseline and Week 8 |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Forced Vital Capacity (FVC) | Forced Vital Capacity (FVC) is measured via spirometry and expressed as a percentage of the predicted value. Higher percentages indicate better pulmonary volume and respiratory function (better outcome). | Baseline and Week 8 |
| Change in Borg Dyspnea Scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Balikesir University Faculty of Medicine | Balıkesir | Turkey (Türkiye) |
De-identified data and the analysis code are available from the corresponding author upon reasonable request.
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000089183 | Axial Spondyloarthritis |
| D004417 | Dyspnea |
| ID | Term |
|---|---|
| D025242 | Spondylarthropathies |
| D025241 | Spondylarthritis |
| D013166 | Spondylitis |
| D013122 | Spinal Diseases |
Not provided
Not provided
A prospective, single-arm, open-label pilot study to evaluate the feasibility and efficacy of multimodal pulmonary rehabilitation.
Not provided
Not provided
Not provided
Not provided
|
The Modified Borg Dyspnea Scale is used to assess exertional breathlessness. The scale ranges from a minimum of 0 (no dyspnea at all) to a maximum of 10 (maximal dyspnea). Higher scores indicate more severe breathlessness (worse outcome). |
| Baseline and Week 8 |
| Change in BASFI Score | The Bath Ankylosing Spondylitis Functional Index (BASFI) assesses the degree of functional limitation in daily activities. The scale ranges from a minimum of 0 to a maximum of 10. Higher scores indicate greater functional impairment and disability (worse outcome). | Baseline and Week 8 |
| Change in SF-36 Mental Health Score | The 36-Item Short Form Health Survey (SF-36) is a health-related quality of life questionnaire. The Mental Health domain is scored from a minimum of 0 to a maximum of 100. Higher scores indicate a more favorable mental health state and better well-being (better outcome). | Baseline and Week 8 |
| D001847 |
| Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D000844 | Ankylosis |
| D007592 | Joint Diseases |
| D001168 | Arthritis |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |